Navigation Links
Doing the pharmaceutical tango

The tango is an elaborate, elegant, and emotional Argentine dance that embodies a combination of rapid and slow movements. The word tango has worked its way into our vocabulary: "It takes two to tango" means that one person doesn't make a major mistake or screw-up, it usually requires the work of two.

The tango often seems like a battle of two people trying......

Full article >>> percent of Merck's 2005 worldwide sales - totaling $22 billion - were from in-licensed products.

This number is actually even higher as it doesn't reflect the co-marketing deal with Schering-Plough for the cholesterol drug Zetia, which Merck doesn't reflect as sales, but does have an important income impact. ......

Full article >>> to the WSJ article, the combination of German Merck/Serono will be known as Merck-Serono Biopharmaceuticals for the prescription drug part of the business, with its headquarters in Geneva and Boston (both Serono operations). It also will have combined annual pharma sales of about $4.6 billion, an annual R&D budget of about $1.3 billion, and a worldwide sales force of 7,000.

More than th......

Full article >>> ompanies into the top tier ranks of pharma companies. The 10th-ranked big pharma company, Wyeth, had 2005 sales of almost $19 billion. In fact, Merck KGaA, Nycomed, and UCB probably will not even crack the list of the top 20 big pharmas. Still, these acquisitions probably were what they could afford, and at least temporarily will allow them to avoid be......

Full article >>> br>
Blue color= 2006 transactions

I think there are still some potential transactions that will take place before the end of the year. Two companies that have been in the target list are Bristol-Myers Squibb and Schering-Plough.

Bristol-Myers Squibb currently has a market valuation of about $49.3 billion, while Schering-Plough's is $31.7 bill......

Full article >>> ished, with a price of about $44/share in 2002 compared to about $28/share today, or a drop of 36 percent.

This drop has rankled Pfizer shareholders as McKinnell is walking off with a potential $83 billion lump sum payment, according to BioPharm International. Additionally, McKinnell has departed at a time when several Pfizer blockbusters......

Full article >>> technology Industry Organization. He can be reached at rosenmichaels@aol.com.

The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made ......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 09/26/06


Related biology technology :

1. Life Science: From company creation to growth: Doing business in Wisconsin
2. Doing it Right: Business IT Fusion for the Future
3. Want to squeeze U.S. pharmaceutical companies? Be careful what you ask for
4. Online retailing "tango" is adding some steps
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017  Champions Oncology, ... in the development and sale of advanced technology solutions ... oncology drugs, today announced the addition of new cohorts ... These new models will expand Champions, product line ... head and neck cancer, AML, and non-small cell lung ...
(Date:2/16/2017)... LAFAYETTE, Indiana (PRWEB) , ... ... ... division of Albany Molecular Research Inc. has further extended its industry leading ... This service offers state-of-the-art cGMP techniques and methods for the ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)... -- A new independent identity strategy consultancy firm announces ... Designed to fill a critical niche in technical and ... Mark Crego and Janice Kephart ... expertise that span federal governments, the 9/11 Commission, private ... expertise has a common theme born from a shared ...
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
Breaking Biology News(10 mins):